• Subscribe
  • Newsfeed
  • About
  • Jobs
Announce News

Northpond Ventures

To add a bio or update investment portfolio click update information.

Investment Portfolio

    Mestag Therapeutics secures £30m to advance fibroblast immunology cancer therapiesMestag Therapeutics secures £30m to advance fibroblast immunology cancer therapies
    Mestag Therapeutics
    16 Mar 2026

    Mestag Therapeutics secures £30m to advance fibroblast immunology cancer therapies

    Mestag Therapeutics develops antibody treatments based on fibroblast immunology for cancer and inflammatory diseases. It is building therapies designed to direct and drive immune responses using fibroblast-immune biology.

Northpond Ventures
    • Life Sciences
  • 1(12 months)
  • npv.vc
  • Update Information

More venture news

  • Earth Blox secures £6m in funding led by PXN Ventures to turn natural risk into financial insights
    Earth Blox
    19 Mar 2026

    Earth Blox secures £6m in funding led by PXN Ventures to turn natural risk into financial insights

    EquityClimate
  • Chalkie lands a £3m round from TriplePoint Ventures for curriculum-aligned lesson planning software
    Chalkie
    20 Mar 2026

    Chalkie lands a £3m round from TriplePoint Ventures for curriculum-aligned lesson planning software

    EquityEducation
  • Regeno secures £420k in funding from SFC and One Planet Capital for ground-level serviceable wind turbines
    Regeno
    20 Mar 2026

    Regeno secures £420k in funding from SFC and One Planet Capital for ground-level serviceable wind turbines

    EquityEnergy

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn